financetom
Business
financetom
/
Business
/
What's Going On With Ford Stock Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Ford Stock Wednesday?
Mar 5, 2025 11:17 AM

Ford Motor Company ( F ) shares are trading higher on Wednesday. Investors may be assessing trade policy along with President Donald Trump’s plans to make interest payments on automobile loans tax deductible for U.S.-made vehicles.

The Details: According to Reuters, the Trump administration is contemplating suspending the 25% tariff on imports from Canada and Mexico for certain products that comply with the USMCA trade agreement, which primarily affects the automotive industry.

Specifically, automakers could be granted a 30-day exemption from the tariffs. However, for the exemption to become permanent, the companies would need to demonstrate plans to invest more in U.S. automobile production.

On Tuesday, Trump met with the CEOs of Ford, General Motors, and Stellantis to discuss the potential 30-day exception. Vehicle manufacturers are open to increasing their investments in the U.S. auto sector, but they are seeking clarity on tariff policies and environmental regulations

Continued tariffs on Canadian and Mexican imports would significantly increase costs for automakers like Ford. Investors may be reacting positively to the possibility of a tariff exemption.

During his congressional address earlier this week, Trump mentioned plans to make interest payments on automobile loans tax deductible for U.S.-made vehicles, per USA Today. This could incentivize consumers to purchase U.S.-made cars, potentially boosting profits for automobile makers. Investors may also be reacting positively to this potential boost.

See Also: This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

F Price Action: At the time of writing, Ford stock is moving 4.51% higher at $9.53, according to data from Benzinga Pro.

Image: via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Castor Maritime Takes Delivery of Containership Vessel
Castor Maritime Takes Delivery of Containership Vessel
Oct 7, 2024
10:49 AM EDT, 10/07/2024 (MT Newswires) -- Castor Maritime ( CTRM ) took delivery of the M/V Raphaela containership vessel on Thursday. The 1,850 20-foot equivalent unit vessel, built in 2008, was bought with cash on hand, the company said Monday in a statement. The acquisition was announced on Sept. 10 for $16.5 million The vessel was booked under a...
SKYX Platforms Secures $11 Million Strategic Investment
SKYX Platforms Secures $11 Million Strategic Investment
Oct 7, 2024
10:53 AM EDT, 10/07/2024 (MT Newswires) -- SKYX Platforms ( SKYX ) said Monday it secured an $11 million strategic investment in the form of a new class of its preferred stock, with a conversion price of $2 per common share. The investment was led by Shaner Hotel Group Chief Executive and Chairman Lance Shaner and joined by other SKYX...
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
Oct 7, 2024
10:50 AM EDT, 10/07/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Monday it agreed to sell Oramed Pharmaceuticals and affiliates of Murchinson and 3i $50 million of a new tranche B senior secured convertible notes and warrants to purchase up to 7.5 million shares in a registered direct offering. The notes come with an original issued discount of...
Galecto to Focus on Cancer, Liver Disease After Strategic Review; Shares Fall
Galecto to Focus on Cancer, Liver Disease After Strategic Review; Shares Fall
Oct 7, 2024
10:48 AM EDT, 10/07/2024 (MT Newswires) -- Galecto ( GLTO ) said Monday that following a strategic review it has decided to focus on cancer and liver disease. The company said it will leverage its clinical asset GB1211, which has shown positive results in clinical studies on non-small cell lung cancer and decompensated cirrhosis. Galecto ( GLTO ) said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved